Hemiablation prospective multicentric study

On October 7^th 2016, European Urology journal has published the multicentric hemiablation study promoted by the French Association of Urology and lead by Pr Pascal Rischmann. This publication is a major step validating the efficacy of HIFU therapy in general and the focal strategy in particular.

Independent study promoted by the French Association of Urology
(not industry sponsored)

In the United States, Ablatherm^® HIFU is indicated for the ablation of prostate tissue.